TuesdayApr 30, 2013 9:19 am

Islet Sciences, Inc. (ISLT) Announces Receipt of Japanese Patent Covering New Diabetes Medications

Biotechnology company Islet Sciences has announced the receipt of a Japanese patent for allowed claims covering new medications for diabetes. The notice of allowed claims for Patent Application No. 2008-529208 includes the use and composition for small molecules in preventing or treating pathological inflammatory or autoimmune condition – in particular, type 1 diabetes, atherosclerosis, type 2 diabetes, disorders related to visceral obesity, multiple sclerosis, inflammatory bowel disease, psoriasis, rheumatoid arthritis, and Alzheimer’s disease. The patent signifies an additional aspect to the value of Islet Sciences’ therapies, which represent a large market opportunity for the diabetic community and also for the…

Continue Reading

TuesdayApr 30, 2013 9:17 am

Echelon Corp. (ELON) Announces Partnership with ITOCHU and Mitsui for Street Lighting Control System Pilots in Japan

Echelon, the world's leading open standard energy control networking company, announced several leading Japanese cities are now piloting street lighting management systems based on technology from Echelon after witnessing the company's successful demonstration of intelligent street lighting control in the Japanese technology city of Tsukuba in 2011. The piloted systems are configured on the open ISO/IEC 14908 standard and implemented using Echelon's Power Line Communications (PLC) transceivers and segment controllers. ITOCHU Corporation, an Echelon partner, has installed the second phase in the city of Tsukuba. This project was accomplished in cooperation with Panasonic and Toshiba, major Japanese lighting device manufacturers.…

Continue Reading

TuesdayApr 30, 2013 9:13 am

Emisphere Technologies, Inc. (EMIS) and Novo Nordisk (NVO) Amend Development and License Agreement

Emisphere Technologies, a biopharm company, and Novo Nordisk A/S have amended their development and license agreement under which the companies are working to develop and commercialize oral formulations of Novo Nordisk's proprietary GLP-1 receptor agonists, which have the potential of treating Type 2 diabetes, using Emisphere's Eligen® technology. Per the amendment, Novo Nordisk will pay to Emisphere $10 million as a prepayment of development milestone payments that would have otherwise been paid to Emisphere upon the initiation of phase II and phase III testing of an oral GLP-1 product by Novo Nordisk. Novo Nordisk is currently conducting phase I trials…

Continue Reading

TuesdayApr 30, 2013 9:09 am

Rand Worldwide, Inc. (RWWI) Division Announces Release of Powerful, New Scan to BIM™ 2014 Software

Rand Worldwide, a prominent supplier of technology solutions to organizations with engineering design and information technology requirements worldwide, announced today that its IMAGINiT Technologies division has released its innovative Scan to BIM 2014 software. This new software enables streamlined workflows from intelligent 3D data from captured laser scans by utilizing the new Autodesk ReCap Point Cloud Engine. In addition to providing powerful new features, the new software package maintains complete compatibility with the Autodesk Revit 2014. "By keeping our software development in lockstep with Autodesk software rollouts, we ensure customers are able to leverage every benefit that a new release…

Continue Reading

TuesdayApr 30, 2013 8:55 am

Rainbow Coral Corp. (RBCC) Prepares for Revolution in Pharmaceutical and Insurance Industries

The rapid growth of personalized genomic medicine is poised to radically change not only the way that pharmaceutical companies develop drugs, but the way insurance companies administer healthcare plans. Acknowledging the increasing momentum, Rainbow Coral today told investors that it is forging ahead with plans for new partnerships in both genetic testing and companion diagnostics. PricewaterhouseCoopers predicts that the personalized medicine sector could grow to as much as $452 billion by 2015. One of the driving forces behind this expansion is the inefficient way in which drugs are currently produced. Because insurance companies try to avoid paying for drugs that…

Continue Reading

TuesdayApr 30, 2013 8:23 am

VentriPoint Diagnostics Ltd. (VPTDF) Receives Expanded License from Health Canada

Today, VentriPoint Diagnostics reported receiving an expanded license from Health Canada that allows the company to sell the VMS™ heart analysis system for clinical use in Canada. The expansion was for the NRV™ application for the analysis of 2-D ultrasound images for patients with non-specific heart disease. The NRV™ application will enable healthcare providers to rapidly and accurately assess the status of the right ventricle in all patients that do not have significant congenital heart defects or pulmonary hypertension, yet may have a variety of other conditions. VentriPoint’s VMS-2DE™ heart analysis system will be used in conjunction with the NRV™…

Continue Reading

MondayApr 29, 2013 3:08 pm

India Globalization Capital, Inc. (IGC) Doubles-Down On Chinese Steel, Opens New Hub on Border with Mongolia to Source Supply

India Globalization Capital, which is diversified into related mining, materials, infrastructure, and logistics areas via its family of 100%-owned subsidiaries, reported good news today out of their HK Ironman unit (which owns 95% of Linxi HeFei Economic & Trade Co., Ltd., aka PRC Ironman) that runs an iron ore beneficiation plant on 0.85 square miles of hills outside Chifeng, with ore deposits in the neighborhood of 3M tons, as a new and key shipping hub has been established by the company on the Mongolia-China border. CEO of the Bethesda, Maryland-based IGC, Ram Mukunda, looked back with pride on six strenuous…

Continue Reading

MondayApr 29, 2013 3:00 pm

GlobalWise Investments, Inc. (GWIV) and Muratec America Ink New Channel Sales Partnership

GlobalWise Investments and its wholly owned subsidiary Intellinetics, a leading-edge technology company focused on the design, implementation, and management of cloud-based Enterprise Content Management (“ECM”) systems, today announced the signing of a new channel sales partnership with Muratec America, Inc. (www.muratec.com). Headquartered in Plano, TX, Muratec America is a U.S. based subsidiary of Muratec Machinery, Ltd., a privately held Japanese multinational corporation founded in 1935. Known throughout North and South America, Muratec America manufactures workgroup A4 (letter/legal) multifunction printing solutions and provides managed document services components. Muratec America has an experienced sales force and over 500 dealers in North America.…

Continue Reading

MondayApr 29, 2013 1:18 pm

International Stem Cell Corp. (ISCO) Gives Lifeline Skin Care the Winning Edge

On the Lifeline Skin Care website (www.LifelineSkinCare.com) it says “Someday, stem cells will change the world. Today, stem cells will change your skin.” Lifeline Skin Care, a subsidiary of International Stem Cell Corp., produces stem cell based skin care products, leveraging technology only available through its association with ISCO. Although the application of stem cells and their regeneration properties to skin rejuvenation has been heavily popularized, Lifeline Skin Care’s offerings are unique. Specifically, Lifeline stem cell creams are the only products in the world that contain human, non-embryonic stem cell extracts. This is possible because of ISCO’s development of parthenogenesis,…

Continue Reading

MondayApr 29, 2013 11:17 am

University of Kansas Study Highlights Voice Assist, Inc. (VSST) Hands-Free Mobile Solution to Distracted Driving

Voice Assist provides mobile speech and hands-free communication solutions applicable for smart phones, tablet PCs, and other network-connected devices. The company recently highlighted the results of a recent study on distracted driving, conducted by the University of Kansas, School of Architecture, Design & Planning. An alarming increase in the number of automobile crashes attributed to distracted drivers has spurred legislative action to curb the use of electronics while driving. Many cities have already implemented laws against driving and texting, as well as laws against cell phone use unless it is a hands-free connection. In correlation, the University of Kansas in…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered